bazedoxifene has been researched along with Atypical Endometrial Hyperplasia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beachler, DC; Dai, D; Daniels, K; Fournakis, N; Frajzyngier, V; Garg, RK; Governor, S; Hoffman, SR; Lanes, S; Mcmahill-Walraven, CN; Seals, RM; Shen, R; Shuminski, P; Wang, FT; Zhou, X; Ziyadeh, NJ | 1 |
| Appt, SE; Clarkson, TB; Cline, JM; Ethun, KF; Register, TC; Wood, CE | 1 |
| Chines, AA; de Villiers, TJ; Hines, T; Levine, AB; Mirkin, S; Nardone, Fde C; Palacios, S; Williams, R | 1 |
| Archer, DF; Chines, AA; Harvey, JA; Lindsay, R; Mirkin, S; Pan, K; Pinkerton, JV | 1 |
| Archer, DF; Kagan, R; Komm, BS; Mirkin, S; Pan, K; Pickar, JH; Pinkerton, JV; Thompson, JR | 1 |
| Choe, GH; Flannery, CA; Fleming, AG; Naqvi, H; Sharma, A; Taylor, HS; Zhang, M | 1 |
| Gillespie, JA; Parish, SJ | 1 |
| Bachmann, G; Pickar, JH; Speroff, L; Yeh, IT | 1 |
| Levine, JP | 1 |
| Chines, AA; Komm, BS; Mirkin, S; Pan, K | 1 |
2 review(s) available for bazedoxifene and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Topics: Age Factors; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Drug Administration Routes; Drug Combinations; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Osteoporosis, Postmenopausal; Quality of Life; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sleep Wake Disorders; Time Factors; Vagina | 2017 |
Treating menopausal symptoms with a tissue-selective estrogen complex.
Topics: Atrophy; Body Mass Index; Climacteric; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; Vasomotor System; Vulva; Women's Health | 2011 |
5 trial(s) available for bazedoxifene and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.
Topics: Aged; Bone Density Conservation Agents; Carcinoma, Ovarian Epithelial; Double-Blind Method; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Incidence; Indoles; Middle Aged; Neoplasms, Glandular and Epithelial; Osteoporosis, Postmenopausal; Ovarian Neoplasms; Postmenopause; Selective Estrogen Receptor Modulators; Spinal Fractures; Ultrasonography; Vaginitis | 2013 |
Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Indoles; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Selective Estrogen Receptor Modulators; Treatment Outcome | 2014 |
Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
Topics: Bone Density; Bone Density Conservation Agents; Breast; Drug Therapy, Combination; Endometrial Hyperplasia; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Selective Estrogen Receptor Modulators; Uterine Hemorrhage | 2016 |
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Middle Aged; Outpatients; Postmenopause; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Treatment Outcome | 2009 |
Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Endometrial Hyperplasia; Estrogens, Conjugated (USP); Female; Humans; Indoles; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Selective Estrogen Receptor Modulators | 2013 |
3 other study(ies) available for bazedoxifene and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study.
Topics: Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Selective Estrogen Receptor Modulators; United States | 2023 |
Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model.
Topics: Animals; Cell Proliferation; Drug Evaluation, Preclinical; Endometrial Hyperplasia; Endometrium; Estrogen Receptor alpha; Estrogens, Conjugated (USP); Female; Gene Expression; Indoles; Macaca fascicularis; Models, Animal; Ovariectomy; Random Allocation; Selective Estrogen Receptor Modulators | 2013 |
Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.
Topics: Adult; Aged; Aged, 80 and over; Animals; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Endometrioid; Case-Control Studies; Cells, Cultured; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fibroblast Growth Factors; Gene Expression Profiling; Humans; Indoles; Mice; Middle Aged; Selective Estrogen Receptor Modulators | 2016 |